Liver transplantation.

Area of Science:

• Hepatology and Transplant Surgery
• Immunosuppression Therapy
• Organ Allocation Policy

Background:

• Liver transplant survival rates have improved due to advancements in immunosuppression and surgical techniques.
• Early steroid reduction in immunosuppression regimens aims to minimize long-term side effects while maintaining efficacy.
• Organ allocation controversies and organ shortages have spurred innovation, including living-donor liver transplantation.

Purpose of the Study:

• To review recent advances and ongoing challenges in liver transplantation.
• To evaluate the efficacy and safety of new immunosuppressive strategies and surgical approaches.
• To discuss the impact of recurrent viral hepatitis on long-term transplant outcomes.

Main Methods:

• Review of current literature and clinical practices in liver transplantation.
• Analysis of outcomes data for various immunosuppression protocols and surgical techniques.
• Assessment of the effectiveness of antiviral therapies and their limitations.

Main Results:

• Newer immunosuppression and early steroid withdrawal show promise in improving outcomes and reducing side effects.
• Living-donor liver transplantation and the use of right-lobe grafts are expanding options, particularly in adult recipients.
• Recurrent hepatitis B, despite lamivudine treatment, poses a significant challenge due to resistance; hepatitis C shows good short-term survival but long-term fibrosis progression requires further study.

Conclusions:

• Continued advancements in immunosuppression and surgical techniques are enhancing liver transplant success.
• Addressing organ shortages through innovative approaches like living donation is crucial.
• Long-term management of recurrent viral hepatitis remains a critical area for research to improve patient survival and quality of life post-transplant.